0
Damora Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
0
FY23:
0
FY24:
0
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−52.2
FY22:
−61.2
FY23:
−39.9
FY24:
−22.3
FY25:
−211
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
–
FY25:
−211
(positive)
Change from FY21 to FY25
millions USD
FY21:
−51.8
FY22:
−61.6
FY23:
−38.3
FY24:
−21.4
FY25:
−210
(positive)
Change from FY21 to FY25
millions USD
FY21:
−51.8
FY22:
−61.6
FY23:
−38.3
FY24:
−21.4
FY25:
−210
All amounts in millions USD